Synthetic Biology Patent Applications Expected to Present New Challenges
June 6, 2008
Foley Partner Mark Waxman and Patent Agent Vid Mohan-Ram recently authored an article titled, “Synthetic Biology Patent Applications Expected to Present New Challenges,” in the June 6, 2008 issue of Life Sciences Law & Industry Report. The article addresses the U.S. patent applications that expressly focus on synthetic biology, and how the U.S. Patent & Trademark Office is handling and examining them.
Reproduced with permission from Life Sciences Law & Industry Report, Vol. 2, No. 12 (June 6, 2008) pp. 473-474. Copyright 2008 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com.
Related Insights
December 8, 2025
Foley Viewpoints
2026 Outlook: AI, IPOs, and the New “Normal” in Venture & Private Equity
Key Takeaways The 2026 outlook for market activity is cautiously optimistic amid ongoing challenges.Private equity firms are shifting to…
December 8, 2025
Labor & Employment Law Perspectives
Colorado Adds New NICU Leave Under FAMLI: What Employers Should Know
Colorado’s Family and Medical Leave Insurance (FAMLI) program has provided employees with paid leave for major life events since 2024,…
December 8, 2025
Labor & Employment Law Perspectives
The Post-Shutdown Compliance Crunch: Preparing for Agency Action
The longest federal government shutdown in U.S. history has ended, and employers must now refocus their attention on agency actions and…